DexCom Inc. closed 39.13% short of its 52-week high of $142.00, which the company achieved on March 26th.

On Monday, DexCom Inc (DXCM) stock saw a decline, ending the day at $87.53 which represents a decrease of $-1.22 or -1.37% from the prior close of $88.75. The stock opened at $88.58 and touched a low ...

The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive drop in its stock price overnight. Though the issues DexCom has faced this year ...

DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $88.75 which represents a slight increase of $1.05 or 1.20% from the prior close of $87.7. The stock opened at $88 and touched a low of ...

Dexcom stock has been steadily gaining value since the crash, rising to $85 per share at the time of writing, although this represents a discount of 35% to its price immediately prior to the Q2 ...

Barclays analyst Matt Miksic lowered the firm’s price target on DexCom (DXCM) to $92 from $113 and keeps an Equal Weight rating on the shares.

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...